Company Overview
- Headquarters
- 157 Church Street, 19th Floor, New Haven CT
- Website
- renetx.com
- Phone
- (203) 444-6642
- Employees
- 7
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$3B
Who is ReNetX Bio
ReNetX Bio is a biotechnology company headquartered in New Haven, Connecticut. The company employs 7 individuals and generates approximately $2.5 million in annual revenue. ReNetX Bio focuses on developing innovative therapeutics for central nervous system (CNS) injuries and diseases. Their primary product, AXER-204, aims to promote neuronal regeneration by inhibiting receptors that hinder axonal growth. This treatment holds promise for conditions like spinal cord injury, glaucoma, and traumatic brain injury. The company's approach distinguishes itself through its focus on rebuilding connections between healthy and damaged neurons, offering a potential breakthrough in treating debilitating CNS conditions. ReNetX Bio's AXER-204 is currently undergoing Phase 2 testing, demonstrating their commitment to advancing clinical research and bringing effective treatments to patients. For more information about ReNetX Bio and their groundbreaking therapies, please visit their website at renetx.com.
Company Leadership
ReNetX Bio Industry Tags
Companies Similar to ReNetX Bio
Analyze industry trends and opportunities by examining competitors and companies comparable to ReNetX Bio, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | Arvada, CO | |||
| 3M | 6 | Star Valley Ranch, WY | ||
| 3M | 4 | Ann Arbor, MI | 2006 | |
| 3M | 3 | San Diego, CA | ||
| 3M | 3 | New York, NY |